Home › Neuroblastoma › Texas › Dallas

Pag-aaral pangklinika para sa Neuroblastoma sa Dallas, TX

9 pag-aaral para sa Neuroblastoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Dallas (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Nagre-recruitPhase 3

Medical City Dallas Hospital, Dallas
UT Southwestern/Simmons Cancer Center-Dallas, Dallas

Hanggang edad 30 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06172296

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

Nagre-recruitPhase 2

Children's Medical Center, Dallas

Hanggang edad 22 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT02559778

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

Nagre-recruitPhase 1/2

Children's Medical Center, Dallas

Hanggang edad 26 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06465199

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

Nagre-recruitPhase 1/2

Children's Medical Center, Dallas

Hanggang edad 30 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06541262

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

Nagre-recruitPhase 2

Children's Medical Center, Dallas

Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06540963

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Nagre-recruitPhase 3

UT Southwestern/Simmons Cancer Center-Dallas, Dallas

365 Days – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT03126916

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

Nagre-recruitPhase 2

University of Texas Southwestern, Dallas

Edad 1 hanggang 31 · Lahat ng kasarian · Na-update Hul 20, 2026 · NCT06450041

Neuroblastoma Biology Study

Nagre-recruitObservasyonal na pag-aaral

University of Texas Southwestern, Dallas

31 Days – 99 Years · Lahat ng kasarian · Na-update Mar 23, 2026 · NCT01587300

Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma

Nagre-recruit

University of Texas Southwestern Medical Center, Dallas

Hanggang edad 17 · Lahat ng kasarian · Na-update Peb 10, 2026 · NCT06831552

Pag-aaral para sa Neuroblastoma sa ibang lungsod

Iba pang pag-aaral sa Dallas

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.